Nrx Pharmaceuticals Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$1.85

+0.01 (+0.54%)

As of Mar 22, 10:47 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +1,050.3% upside

Low Target $14.65

Average Target $21.28

High Target $27.46

Current Price $1.85

Current
$1.85

Target
$21.28

$14.65 $21.28 avg $27.46

Scenario Analysis

Bear Case

$14.65

691.9%

Low target

Base Case

$21.28

+1,050.3%

Avg target

Bull Case

$27.46

+1,384.3%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$3.84

-51.8% from high

52-Week Low

$1.58

+17.1% from low

Target vs 52W High

$21.28

+454.2% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%